- Home
- ERII vs IOVA Comparison
ERII vs IOVA Comparison
Compare ERII & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERII
- IOVA
- Stock Information
- Founded
- ERII 1992
- IOVA 2007
- Country
- ERII United States
- IOVA United States
- Employees
- ERII N/A
- IOVA N/A
- Industry
- ERII Industrial Machinery/Components
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ERII Technology
- IOVA Health Care
- Exchange
- ERII Nasdaq
- IOVA Nasdaq
- Market Cap
- ERII 661.1M
- IOVA 771.4M
- IPO Year
- ERII 2008
- IOVA N/A
- Fundamental
- Price
- ERII $13.88
- IOVA $3.13
- Analyst Decision
- ERII Buy
- IOVA Buy
- Analyst Count
- ERII 3
- IOVA 10
- Target Price
- ERII $18.17
- IOVA $12.22
- AVG Volume (30 Days)
- ERII 409.4K
- IOVA 23.7M
- Earning Date
- ERII 08-06-2025
- IOVA 08-07-2025
- Dividend Yield
- ERII N/A
- IOVA N/A
- EPS Growth
- ERII 9.93
- IOVA N/A
- EPS
- ERII 0.37
- IOVA N/A
- Revenue
- ERII $140,923,000.00
- IOVA $212,679,000.00
- Revenue This Year
- ERII $4.82
- IOVA $86.62
- Revenue Next Year
- ERII $12.97
- IOVA $69.95
- P/E Ratio
- ERII $37.44
- IOVA N/A
- Revenue Growth
- ERII 10.93
- IOVA 11070.12
- 52 Week Low
- ERII $10.86
- IOVA $1.64
- 52 Week High
- ERII $20.27
- IOVA $12.51
- Technical
- Relative Strength Index (RSI)
- ERII 65.66
- IOVA 62.71
- Support Level
- ERII $12.82
- IOVA $1.70
- Resistance Level
- ERII $13.87
- IOVA $4.33
- Average True Range (ATR)
- ERII 0.31
- IOVA 0.35
- MACD
- ERII 0.08
- IOVA 0.17
- Stochastic Oscillator
- ERII 86.89
- IOVA 54.55
About ERII Energy Recovery Inc.
Energy Recovery Inc is an engineering-driven technology company. It is engaged in engineering, designing, manufacturing and supplying solutions that make industrial processes more efficient and sustainable. The company operates in three segments, Water, Emerging Technologies and Corporate. It offers energy recovery devices (ERDs) and pumps as well as related products and services to the global reverse osmosis desalination market. The company derives a majority of the revenue from the Water segment. Geographically, the company operates in the U.S. and other international countries.
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.